Fluent Perla CBD Sublingual Tincture – 600mg
Relief Can Be a Precious Thing – Perla is an Indica-dominant hybrid produced through a cross of Cannabis sativa and Cannabis indica plants and has a ratio of 1:40 THC:CBD. As our first in-house developed strain, Perla has demonstrated a consistently robust cannabinoid profile through numerous laboratory analyses, exhibiting record-breaking quantities of CBD above 29%. The terpene content is rich with an abundance of Linalool and Pinene, providing well-balanced effects in both the body and mind. Perla is a whole-plant product that contains concentrations of CBD, THC (<.8%), and a full range of other natural components found in cannabis including terpenes, flavonoids and other cannabinoids that contribute to the medicinal properties of cannabis.
Current medical literature supports the use of CBD rich products for the treatment of pediatric and drug-resistant epilepsy (in combination with other antiepileptic medications) and chronic neuropathic pain.
THC to CBD Ratio: 40:1
Sold By: Fluent
Leave Your Review: Write A Review[otw_is sidebar=otw-sidebar]
Out of stock
Tinctures are absorbed sublingually, so essential cannabinoids are absorbed directly into the bloodstream. Effects are delayed through the absorption process but are prolonged. The application is very discreet, with no odor.[otw_is sidebar=otw-sidebar-5]
Perla® oil is to be administered orally. The starting dose is 2.5 mg/kg twice daily (5 mg/kg/day). Patients are recommended to initiate treatment on the evening of Day 1 with 2.5 mg/kg. After 5-7 days, the dose can be gradually increased to 5 mg/kg twice a day (10 mg/kg/day). Patients who are tolerating Zeltor® at 5 mg/kg twice daily and who may benefit from a dosage increase can be further titrated to a maximum recommended maintenance dosage of 10 mg/kg twice daily (20 mg/kg/day). This should be titrated over several weeks, as tolerated. Dosage should not be increased more frequently than every other day.
Perla® is contraindicated in patients:
• with hypersensitivity to cannabinoids (e.g., THC or CBD) or to any of the inert ingredients in Perla®;
• with a significant history of cardiovascular disease;
• with an active or previous psychotic or active mood or anxiety disorder; and
• who are pregnant, planning to become pregnant, or are breastfeeding.